Updated March 29 at 12:29am
Biotechnology
42 results total, viewing 11 - 20
A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
IlluminOss Medical has been issued two patents related to its internal bone fixing system, the company announced Tuesday. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
Mnemosyne Pharmaceuticals Inc. appointment of Vanessa King as president and CEO. more
The Bill and Melinda Gates Foundation has awarded a $100,000 grant to the GAIA Vaccine Foundation to raise awareness about the prevention of cervical cancer in West Africa. more
The Spectranetics Corp. will acquire Covidien PLC’s Stellarex drug-coated angioplasty balloon platform for $30 million. more
Venture capital firm SV Life Sciences has acquired a majority interest in Ximedica from co-founders Stephen Lane and Aidan Petrie. more
Cadence Inc. celebrated the expansion of its facility with a ribbon cutting ceremony on Oct. 30. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »